Literature DB >> 31141361

Triphenylphosphonium Analogues of Betulin and Betulinic Acid with Biological Activity: A Comprehensive Review.

Mirosława Grymel1,2, Mateusz Zawojak1, Jakub Adamek1,2.   

Abstract

Naturally occurring pentacyclic lupane triterpenoids such as betulin (1) or betulinic acid (2) and their synthetic derivatives display a broad spectrum of biological activities and, therefore, have been the subject of great interest. However, the use of these compounds as potential therapeutic agents is limited by their low bioavailability, high hydrophobicity, and insufficient intracellular accumulation. In this context, research on modifications of the parent structures that will improve their pharmacokinetic properties is particularly important. In the past few years, methods of synthesis as well as cytotoxic and antiparasitic properties of a series of lupane triterpenoids modified by introducing one or two triphenylphosphonium moieties at the C-2, C-3, C-28, or C-30 positions by carbon-carbon or ester bonds have been described. The presence of triphenylphosphonium groups affects not only physical properties but also the mechanism of action of a potential drug. This review summarizes published findings on synthetic methods and biological properties of the triphenylphosphonium derivatives of betulin and betulinic acid.

Entities:  

Year:  2019        PMID: 31141361     DOI: 10.1021/acs.jnatprod.8b00830

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  12 in total

1.  Synthesis, cytotoxicity and anti-inflammatory activity of rhamnose-containing ursolic and betulinic acid saponins.

Authors:  Balla Sylla; Serge Lavoie; Jean Legault; Charles Gauthier; André Pichette
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 4.036

2.  Dealkenylative Alkenylation: Formal σ-Bond Metathesis of Olefins.

Authors:  Manisha Swain; Gusein Sadykhov; Ruoxi Wang; Ohyun Kwon
Journal:  Angew Chem Int Ed Engl       Date:  2020-08-28       Impact factor: 15.336

Review 3.  Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.

Authors:  Sophie Hoenke; Immo Serbian; Hans-Peter Deigner; René Csuk
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 4.  Chemical Strategies towards the Synthesis of Betulinic Acid and Its More Potent Antiprotozoal Analogues.

Authors:  André Barreto Cunha; Ronan Batista; María Ángeles Castro; Jorge Mauricio David
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

5.  Design and Synthesis of Novel Betulin Derivatives Containing Thio-/Semicarbazone Moieties as Apoptotic Inducers through Mitochindria-Related Pathways.

Authors:  Jiafeng Wang; Jiale Wu; Yinglong Han; Jie Zhang; Yu Lin; Haijun Wang; Jing Wang; Jicheng Liu; Ming Bu
Journal:  Molecules       Date:  2021-10-21       Impact factor: 4.411

Review 6.  The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.

Authors:  Siarhei A Dabravolski; Vasily N Sukhorukov; Vladislav A Kalmykov; Andrey V Grechko; Nikolay K Shakhpazyan; Alexander N Orekhov
Journal:  Biomedicines       Date:  2022-01-24

7.  Synthesis of 3-O-Acetyl-11-keto-β-boswellic Acid (AKBA)-Derived Amides and Their Mitochondria-Targeted Antitumor Activities.

Authors:  Changhao Li; Qiaobian He; Yuwen Xu; Hongxiang Lou; Peihong Fan
Journal:  ACS Omega       Date:  2022-03-07

8.  Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress.

Authors:  Yun Chen; Xiongjian Wu; Chi Liu; Yun Zhou
Journal:  Cell Biochem Funct       Date:  2020-04-13       Impact factor: 3.685

Review 9.  Multiple Myeloma Inhibitory Activity of Plant Natural Products.

Authors:  Karin Jöhrer; Serhat Sezai Ҫiҫek
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

10.  Synthesis of 2-Aminoethanesulfonamides of Betulinic and Betulonic Acids.

Authors:  N G Komissarova; S N Dubovitskii; O V Shitikova; A V Orlov
Journal:  Chem Nat Compd       Date:  2021-07-13       Impact factor: 0.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.